Glanbia launches EU50 million round of buybacks, boosts dividend
Glanbia PLC on Wednesday launched fresh buyback plans and proposed a dividend boost, on the back of profit growth.
The Kilkenny, Ireland-based sports nutrition company reported pretax profit of $209.2 million in 2025, up from $208.0 million the year prior, as revenue rose to $3.95 billion from $3.84 billion on-year.
Attributable profit advanced to $183.3 million from $164.7 million, while diluted earnings per share ticked up to 73.16 US cents from 62.45 US cents in 2024. Meanwhile, adjusted EPS fell 3.6% on a reported basis and 3.4% at constant exchange rates to 134.93 US cents, reflecting charges related to asset amortisation.
Glanbia has proposed a final dividend of €25.67 euro cents, up from 23.33 euro cents on-year.
Its shares fell 7.8% to €16.60 on Wednesday morning in London, but are up 18% in the last 12 months.
The company’s board has approved a new €100 million buyback plan, with the first round for up to €50 million starting Wednesday and due to end by September 30.
Glanbia has appointed J&E Davy, part of Bank of Ireland Group PLC, to carry out the buybacks independently, with repurchases allowed to continue during any closed periods.
The scheme will require Glanbia to renew its existing buyback authority at an annual general meeting on April 29. In 2025, it returned about €197 million via buybacks.
Looking to 2026, the company is targeting at least 85% cash conversion, versus 91% in 2025, and expects each of its three main branches - Performance Nutrition, Dairy Nutrition and Health & Nutrition - to meet medium-term guidance.
Glanbia also eyes adjusted EPS growth from 7% to 11% at constant exchange rates, reversing the measure’s decline in 2025. According to Chief Executive Hugh McGuire, this ‘will be driven by category and end-use market demand and a strong operating performance across all three segments.’
McGuire hailed ‘a robust performance in 2025, despite a challenging macroeconomic and operating environment.’
‘We delivered volume and like-for-like revenue growth across all three segments, with performance somewhat offset by record whey inflation.’
‘In parallel, we are advancing our group-wide transformation programme, targeting annual cost savings of $60 million by 2027,’ the CEO added.
Copyright 2026 Alliance News Ltd. All Rights Reserved.